Anzemet
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Anzemet, covering 2017-03-28 to 2025-01-01. Get the full timeline:
Most recent: Clinical Trial Update: Dolasetron for the Prevention of CINV in Children With Acute Lymphoblastic Leukemia